Loading…
Loading…
U.S. President Donald Trump's administration sided with OpenAI in a lawsuit brought by The New York Times, defending training AI models on copyrighted works, according to a court document filed Tuesday.
NEW YORK--(BUSINESS WIRE)-- #AlpineInTheCity--The untold story of New York in Moncler began when snow met concrete. What could have melted instead endured, forging a love built on pioneering moments and strengthened with every chapter. They found each other, again and again. Decades later, their story is finally ready to be shared. Revealed through one of the largest open-air public exhibitions the city has ever seen, New York in Moncler unveils the peak moments that capture the bond between New York and Moncler,.
New York, New York and New Orleans, Louisiana--(Newsfile Corp. - September 2, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Wix.com Ltd.
The department argued in a court filing that OpenAI legally used articles by The New York Times to develop A.I., adding that national security depended on American tech dominance.
The Trump administration has filed a brief supporting OpenAI in its dispute with the New York Times and several other newspapers over the company's use of their work to train the large language models behind ChatGPT, saying AI training generally makes fair use of copyrighted material.
NEW YORK--(BUSINESS WIRE)--The New York Times Company (NYSE: NYT) announced today that it will participate in the Citi Global TMT Conference on Wednesday, September 9, 2026, in New York City. William Bardeen, Executive Vice President and CFO, will participate in a fireside chat at 9:30am a.m. ET, which will be accessible via live webcast at investors.nytco.com. An archive of the webcast will be available on the company's website for one year. About The New York Times Company The New York Times.
ROCKVILLE, Md., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company's management will participate in four upcoming investor conferences in New York, New York.
Orlando, Florida--(Newsfile Corp. - August 31, 2026) - M-tron Industries, Inc. (NYSE American: MPTI) ("Mtron" or the "Company") today announced its participation at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference, taking place on September 9 – 10, 2026, in New York, New York. Cameron Pforr, Chief Executive Officer, and Chris Nossokoff, Vice President – Financial Reporting, will be attending the conference, delivering an investor presentation and participating in scheduled 1-on-1 meetings with investors.